Evidence map›Paper›PMID 35527911›Full record

ArticleRSC advances2019

Jiajia Cui, Xiwang Zheng, Dongli Yang, Yinghuan Hu, Changming An, Yunfeng Bo, Huizheng Li, Yuliang Zhang, Min Niu, Xuting Xue and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Advancement ofChinese herbal medicines · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Jiajia CuiShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Xiwang ZhengShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Dongli YangShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Yinghuan HuShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Changming AnDepartment of Head and Neck Surgery, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100021 China.
Yunfeng BoDepartment of Pathology, Shanxi Cancer Hospital, Shanxi Medical University Taiyuan 030001 Shanxi China.
Huizheng LiDepartment of Otolaryngology Head & Neck Surgery, Dalian Municipal Friendship Hospital Dalian 116001 Liaoning China.
Yuliang ZhangShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Min NiuShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Xuting XueShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Yan LuDepartment of Otolaryngology Head & Neck Surgery, The First Hospital, Jinzhou Medical University Jinzhou 121001 Liaoning China.
Yemei TangShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Hongyu YinShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.
Zhenyu LiModern Research Center for Traditional Chinese Medicine, Shanxi University Taiyuan 030001 Shanxi China lizhenyu@sxu.edu.cn.ORCID https://orcid.org/0000-0003-0655-6942
Wei GaoShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.ORCID https://orcid.org/0000-0001-7836-2851
Yongyan WuShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University Taiyuan 030001 Shanxi China wuyongyan@sxent.org gaoweisxent@sxent.org.ORCID https://orcid.org/0000-0003-1669-3860
Shanxi Medical University · CNAcademy of Medical Sciences · GBDalian University · CNJinzhou Central Hospital · CNShanxi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laryngeal squamous cell carcinoma (LSCC) is the most common head and neck cancer.

Identifiers

PMID35527911
PMCPMC9069756
OpenAlexW2965203310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.